Non-Hodgkin's Lymphoma Reversal with Dichloroacetate

被引：11

作者：

Flavin, Dana F. ^{[1
,2
]}

机构：

[1] Klin Alpenpk, Defreggerweg 2-6, D-83707 Ringsee, Tegernsee, Germany

[2] Fdn Collaborat Med & Res, Greenwich, CT 06830 USA

来源：

JOURNAL OF ONCOLOGY | 2010年 / 2010卷

关键词：

D O I：

10.1155/2010/414726

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In June 2007, a 48-year-old male patient, diagnosed with Stage 4 Non-Hodgkin's Follicular Lymphoma (NHL), was treated for 3 months with conventional chemotherapy resulting in a complete remission. Almost one year later tumors returned in the nasopharynx and neck lymph glands. Refusing all suggested chemotherapies, the patient began self-administering dichloroacetate (DCA) 900 mg daily with a PET scan showing complete remission four months later. Since his last PET scan, May, 2009, he remains tumor- free from continuous DCA usage.

引用

页数：4

共 27 条

[1]

Armitage J. O., 2005, HARRISONSS PRINCIPLE, P642

[2] Therapeutic potential of dichloroacetate for pyruvate dehydrogenase complex deficiency [J].

Berendzen, Kristen ;

Theriaque, Douglas W. ;

Shuster, Jonathan ;

Stacpoole, Peter W. .

MITOCHONDRION, 2006, 6 (03) :126-135

[3] A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth [J].

Bonnet, Sebastien ;

Archer, Stephen L. ;

Allalunis-Turner, Joan ;

Haromy, Alois ;

Beaulieu, Christian ;

Thompson, Richard ;

Lee, Christopher T. ;

Lopaschuk, Gary D. ;

Puttagunta, Lakshmi ;

Bonnet, Sandra ;

Harry, Gwyneth ;

Hashimoto, Kyoko ;

Porter, Christopher J. ;

Andrade, Miguel A. ;

Thebaud, Bernard ;

Michelakis, Evangelos D. .

CANCER CELL, 2007, 11 (01) :37-51

[4]

Boutwell R. K., 1978, CARCINOGENSIS MECH T, P29

[5] Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiation [J].

Cao, Wengang ;

Yacoub, Saif ;

Shiverick, Kathleen T. ;

Namiki, Kazunori ;

Sakai, Yoshihisa ;

Porvasnik, Stacy ;

Urbanek, Cydney ;

Rosser, Charles J. .

PROSTATE, 2008, 68 (11) :1223-1231

[6] DISPOSITION AND PHARMACODYNAMICS OF DICHLOROACETATE (DCA) AND OXALATE FOLLOWING ORAL DCA DOSES [J].

CURRY, SH ;

LORENZ, A ;

CHU, PI ;

LIMACHER, M ;

STACPOOLE, PW .

BIOPHARMACEUTICS & DRUG DISPOSITION, 1991, 12 (05) :375-390

[7]

Donohue J.M., 2003, TOXICOLOGICAL REV DI

[8] Human kinetics of orally and intravenously administered low-dose 1,2-13C-dichloro acetate [J].

Jia, Minghong ;

Coats, Bonnie ;

Chadha, Monisha ;

Frentzen, Barbara ;

Perez-Rodriguez, Javier ;

Chadik, Paul A. ;

Yost, Richard A. ;

Henderson, George N. ;

Stacpoole, Peter W. .

JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (12) :1449-1459

[9] A systematic overview of chemotherapy effects in aggressive non-Hodgkin's lymphoma [J].

Kimby, E ;

Brandt, L ;

Nygren, P ;

Glimelius, B .

ACTA ONCOLOGICA, 2001, 40 (2-3) :198-212

[10]

KRISHNA S, 1995, QJM-MON J ASSOC PHYS, V88, P341

← 1 2 3 →